Makovsky Adds Financial and Healthcare Clients
Charting the future of public relations
Holmes Report
CEO

Makovsky Adds Financial and Healthcare Clients

Mirae Asset Global Investments (USA), a unit of Mirae Asset Global Investments (Hong Kong), has selected Makovsky + Co. to develop and implement an integrated marketing campaign to introduce the firm’s range of emerging market investment products.

Paul Holmes

NEW YORK—Mirae Asset Global Investments (USA), a unit of Mirae Asset Global Investments (Hong Kong), has selected Makovsky + Co. to develop and implement an integrated marketing campaign to introduce the firm’s range of emerging market investment products to institutional and retail investors in the U.S. 

 

Mirae Asset is one of the largest emerging markets equity investors worldwide with over $36 billion in emerging market equities under management. “With the substantial growth in emerging markets investing globally, Mirae Asset sees a great opportunity for our expertise in the U.S. market,” says Jay Jang, president and CEO of Mirae Asset (USA).  “Bringing rich financial services expertise in reaching the retail and institutional markets, Makovsky + Co. is the ideal partner for our firm’s multi-disciplined program.”

 

At the same time, Neoprobe Corporation, a diversified developer of innovative biomedical surgical oncology products, today announced that it has retained Makovsky + Company for the development of a strategic communications and investor relations program.

 

According to David Bupp, Neoprobe’s president and CEO, said, “Makovsky + Company’s experience in working with emerging heath and small cap companies was a determining factor in our decision to retain the firm.  Our company is at an important stage in its history.  Makovsky will help guide our communications strategy and generate increased investor awareness for our company among key audiences regarding the exciting Neoprobe business initiatives.” 

 

View Style:

Load 3 More
comments powered by Disqus